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THE ROLE OF TWO HOMOLOGOUS E3 LIGASES IN MUSCLE PHYSIOLOGY

Gabrielle Gloston, B.S.

Advisory Professor: Zheng Chen, Ph.D.
Ubiquitin-mediated proteasomal degradation is an essential cellular function
that is coordinated by three key components: E1 ubiquitin activating enzyme, E2
ubiquitin conjugating enzyme, and E3 ubiquitin ligases. There are an estimated 600
E3 ligases, some of which share high sequence homology; however, the functional
significance often remains unknown. FBXL3 and FBXL21 are two homologous E3
ligases that have previously been reported to dictate circadian periodicity, with
FBXL3 being the dominant E3 ligase and FBXL21 playing a regulatory role. A recent
Yeast Two-Hybrid screen revealed a new shared target of FBXL3 and FBXL21:
Telethonin (also known as TCAP). TCAP is a sarcomeric z-disc protein expressed in
cardiac and skeletal muscle that is critical to proper structure and function of
muscles. Through preliminary experiments, we identified TCAP as a novel shared
target substrate of FBXL3 and FBXL21. Here we report that FBXL3 and FBXL21
both accelerate TCAP degradation; however, FBXL21 is the more potent E3 ligase.
This novel finding underlines the importance of substrate specificity and serves as a
paradigm for future mechanistic studies of E3 ligase homologous pairs. Additionally,
the findings reported here will facilitate further studies investigating the role of
FBXL3/21 in muscle physiology.
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CHAPTER 1: INTRODUCTION
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1. Introduction
There are over 600 E3 ligases in the human genome, many of which share
high sequence homology with a small subset of other E3 ligases; however, their
functional relationship often remains unknown. Additionally, each of these ligases
are capable of having multiple target substrates, creating a variety of E3 ligasesubstrate combinations (Harper et al 2012). FBXL3 and FBXL21 are two
homologous E3 ligases that were previously reported to control circadian periodicity
through antagonistic activity on their shared target substrates, CRYPTOCHROME
(CRY) 1 and 2. In relation to CRYs, FBXL3 is the predominant E3 ligase that
promotes degradation in the nucleus and FBXL21 plays a regulatory role by
protecting CRYs in the cytoplasm (Yoo et al 2013).
It is well known that circadian clocks exist within a majority of cells throughout
the body, including the muscular system (Harfmann et al 2015). In fact, skeletal
muscles heavily rely on the positive regulators of the circadian oscillator, Bmal1 and
Clock, which have been shown to affect both structure and function of skeletal
muscle when genetically disrupted in mice (Andrews et al 2010). Furthermore,
multiple independent studies now suggest that muscle physiology is tightly clockregulated, making skeletal muscle a suitable candidate to screen for novel protein
targets of FBXL3 and FBXL21 (Harfmann et al 2015; Podobed et al 2014; MayeufLouchart et al 2015).
In a Yeast Two-Hybrid screen, we identified TCAP (also known as Telethonin)
as a shared target substrate of FBXL3 and FBXL21. TCAP is a cytoplasmic protein
that is integral to sarcomeric Z -disc and -line structure and function in both cardiac
1

and skeletal muscle cells, respectively (Valle et al 1997). Interestingly, TCAP has
been shown to be circadian regulated at the mRNA level in cardiac muscle and
mutations in TCAP have been associated with Limb Girdle Muscle Dystrophy
(Podobed et al 2014; Moreira et al 2000). Our lab found that FBXL3 and FBXL21
tightly and specifically bind to TCAP, with E3 ligase activity on TCAP that opposed
the previous paradigm discovered with the CRY proteins. When ectopically
expressed, FBXL21 potently accelerated TCAP degradation, whereas FBXL3
showed a much more diminished effect. Therefore, FBXL3 and FBXL21 play distinct
roles in the degradation of CRYs and TCAP. Given the crucial role that TCAP plays
in the structure and function of skeletal muscle, we suspect that these homologous
E3 ligases serve as important regulators of muscle physiology, just as they govern
periodicity in the circadian clock.
1.1 Ubiquitin-mediated protein degradation
Ubiquitin-mediated protein degradation is a serial, enzymatic reaction that
targets proteins for degradation and is essential to proper cellular functioning
(Harper et al 2012). In fact, disruption of the ubiquitin-proteasome system has been
associated with serious physiological consequences, such as cancers and
neurodegeneration (Welcker and Clurman 2008; Frescas and Pagano 2008; Jin and
Youle 2012). The study of ubiquitin signaling has only been recently advanced within
the last decade. It is currently known that eukaryotes have 2 E1 enzymes, 40 E2
enzymes, and about 600 E3 enzymes. In order to facilitate the proper execution of
protein turnover (and several other ubiquitin-regulated cellular functions), ubiquitin
networks are organized in a finely tuned spatiotemporal fashion (Grabbe et 2011).
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The three major components that are responsible for orchestrating the
ubiquitylation process are: E1 (ubiquitin activating enzyme), E2 (ubiquitin
conjugating enzyme), and E3 (ubiquitin ligase) (Harper et al 2012). Ubiquitin (Ub) is
first activated by the E1 enzyme (Ub activating enzyme) in an ATP-dependent
manner and then becomes Ub-adenylate (ADP). Once activated, Ub is able to form
a thioester bond with one of the 40 E2 enzymes (conjugating enzymes). E2
conjugating enzymes play an important role in determining the number of Ub
molecules attached to a protein as well as the chain linkage type associated with
proteins that are poly-ubiquitinated (Ye and Rape 2009). There are three major
groups of E3 ligases (HECT, RING, or RBR), but regardless of the type, Ub is
transferred from the E2 conjugating enzyme to the substrate. Ultimately, proteins are
either monoubiquitylated, multi-monoubiquitylated or poly-ubiquitylated; these
ubiquitylation modifications are a result of the combination of specific E2 and E3
enzymes.
Despite the importance of ubiquitin-mediated protein degradation, a large
number of E3 ligases remain poorly characterized. Substrates have been difficult to
identify partly because of the transient nature of degradative ubiquitylation targets, in
addition to the weak interactions that typically occur between an E3 ligase and its
substrate (Harper et al 2012). Before advancements in proteomic technology,
substrates were identified by screening for conserved targeting sequences in
proteins throughout the human genome that matched the targeting sequences in
already identified E3 ligase substrates (Koepp et al 1999; Zachariae and Nasmyth
1999; Harper et al 2002; Willems et al 1999). According to the most recent
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predictions (based on E3 functional domains), there are over 600 E3 ligases in the
human genome, a number of which remain completely unstudied (Deshaies and
Joazeiro 2009).
1.2 The mammalian circadian molecular oscillator
The circadian system has evolved to help the body anticipate predictable
environmental changes, allowing the body to optimize its biological processes
throughout Earth’s 24-hour cycles of light and dark. Circadian rhythms are generated
by the activity of core clock circadian genes in what is known as the mammalian
circadian molecular oscillator. This oscillator is ubiquitously expressed in individual
cells throughout most organs in the body and functions autonomously. The most
important circadian clock is located in the suprachiasmatic nucleus (SCN), which
contains around 20,000 neurons with individual molecular oscillators that “tick” in
synchrony throughout the entire SCN. A simplified schematic of the mammalian
circadian molecular oscillator is pictured below in Figure 1. The core molecular
oscillator consists of both positive and negative components. CLOCK and BMAL1
are basic helix-loop-helix/PAS (bHLH/PAS) transcription factors that heterodimerize
and translocate to the nucleus, where they bind to the E- (CACGTG or CACGTT)
box cis-regulatory elements of several circadian genes, including the two other core
circadian genes, Per and Cry. Once bound, these genes are transcriptionally
activated, produce proteins that heterodimerize and then translocate from the
cytoplasm to the nucleus. Once in the nucleus, this PER/CRY complex
transcriptionally represses CLOCK/BMAL1, indirectly repressing their own
transcription. This negative transcriptional regulation serves as the end of a full
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circadian period and through additional posttranscriptional and posttranslational
steps, transcriptional repression is relieved via proteasomal degradation of
PER/CRY (Lowery and Takahashi 2011).
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Figure 1: The mammalian circadian molecular oscillator. The molecular oscillator is
ubiquitously expressed throughout most cells in the body and the fluctuating activity of its
protein products results in circadian rhythms. The core feedback loop consists of BMAL,
CLOCK, PER and CRY. BMAL & CLOCK heterodimerize & transcriptionally activate
clock genes like Per and Cry, serving as the positive arm of this feedback loop. Near the
end of a circadian period, PER & CRY bind to BMAL & CLOCK, serving as a
transcriptional repressor of both the positive and negative arm of this core loop.
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1.3 The role of FBXL3 & FBXL21 in the circadian clock
The mammalian SCF ubiquitin ligase is a multi-protein complex that is crucial
to post-translational regulation of cellular timing via proteasomal degradation. It is
characteristically composed of Skp1, Cul1, and an F-box protein (Cardoza and
Pagano 2004). The F-box protein family is the substrate recognition component of
the SCF ligase and is typically named according to their substrate-binding domain
(Cenciarelli et al 1999; Winston et al 1999). Currently, the F-box family includes
FBWs, FBLs, and FBXs. The FBW family includes F-box proteins featuring
substrate-binding domain with WD-40 repeats. FBL proteins have substrate-binding
domains with leucine-rich repeats (LRRs). The last category of F-box proteins are
the FBXs, which have neither WD-40 repeats nor LRRs in their substrate-binding
domains (Cardoza and Pagano 2004). The full spectrum of protein substrates are
still unknown for many F-box proteins; therefore, the cellular function of many E3
ligases remains unknown. It is expected that these proteins target diverse substrates
and have many different cellular functions, given the variety of structural
compositions currently known (Kipreos and Pagano 2000).
An FBXL3 mutant mouse line (Overtime, Ovtm) was derived from a largescale forward ENU mutagenesis screen and was found to have a circadian period of
25.8 hours. Through positional cloning and genetic complementation, a point
mutation in Fbxl3 was revealed to convert isoleucine to threonine at residue 364.
This mutation is mapped to a region between two leucine rich repeat (LRR) domains
(LRR 10 and LRR 11) located in the C terminus of Fbxl3. Ovtm mice showed a
7

change in circadian gene and protein expression. PER protein levels were
significantly reduced in liver tissue, while CRY2 protein levels showed significant
elevation. All other core clock machinery, such as CLOCK, BMAL1, and CRY1
showed no significant response to the semidominant, autosomal Ovtm mutation.
This mouse model served as genetic evidence that FBXL3 may act as an E3
ubiquitin ligase that targets CRY proteins (Cardoza and Pagano 2004). Cellular
studies showed that while FBXL3 typically promote proteasomal degradation of
CRY, FBXL3OVTM stabilized CRY, resulting in an overall elevation of CRY protein
levels. Siepka et al (2007) concluded that the lengthened circadian period and
complementary phenotypic alterations induced by the Ovtm mutation was caused by
an inefficient FBXL3 protein and transcriptional repression via CLOCK and BMAL1
(Siepka et al 2007).
Recently, another ENU mutagenesis-derived mouse lined called Past-time
was found to have a short circadian period (22.91 hours). Researchers mapped the
mutation to the Fbxl21 gene, more specifically to a point mutation at nucleotide 787
in the 5th exon. Moreover, this mutation causes a conversion of glycine to glutamic
acid at residue 149 in the amino acid sequence, which is expected to destabilize the
LRR domain of FBXL21 protein (Yoo et al 2013). Although small, this mutation is
significant for the functionality of FBXL21 as an E3 ligase because LRR domains
typically facilitate protein-protein interactions via substrate recognition (Kobe and
Kajava 2001). In vivo work revealed that the Psttm mutation affected clock gene
expression by elevating Per1/2 and Cry1/2 mRNA levels in the cerebellum and
moderately so in mouse liver. Clock-controlled genes like Rev-erbα, Dec2, and Dbp
8

were also elevated in liver tissue. Interestingly, CRY protein levels were not elevated
as expected and CRY2 levels were actually reduced, suggesting that the Psttm
mutation affected protein stability leading to a destabilization of CRY2 protein levels
(Yoo et al 2013).
FBXL3 and FBXL21 are two homologous E3 ubiquitin ligases that work in
direct opposition to tightly regulate circadian periodicity in mammals. The circadian
clock is driven by a molecular oscillator that consists of two interlocked loops (Ko
and Takahashi 2006). The core loop is composed of a positive (CLOCK and BMAL1)
and negative (PER1/2 and CRY1/2) arm. Over the course of a single circadian
period, Per and Cry products are translocated to the cytoplasm where they
heterodimerize, return to the nucleus, and eventually repress CLOCK/BMAL1
transcriptional activation, thus turning off their own transcription. When mutated,
FBXL3 and FBXL21 can either lengthen or shorten the circadian period by
modulating CRY protein levels. Further molecular studies based on the initial in vivo
findings revealed that FBXL3 is the active E3 ligase for CRY in the nucleus and
FBXL21 has dual roles (pictured in Figure 2). In the nucleus, FBXL21 is a regulatory
E3 ligase that antagonizes FBXL3 and protects CRY. In the cytoplasm, FBXL21 is a
weak active E3 ligase for CRY (Yoo et al 2013). This was the first study to elucidate
such a unique homologous E3 ligase paradigm. Discovering one substrate of an Fbox protein does not reveal the full gamut of its cellular functions; instead, an E3
ligase typically has multiple target substrates. It is important to note that FBXL21 is
subject to circadian regulation and is a paralogue of FBXL3, with ~85% conserved
amino acid residues between the two (Yoo et al 2013). It is therefore plausible that
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FBXL3 and FBXL21 could share a circadian-regulated target substrate in a similar
paradigm as the one mentioned here with CRY.
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Figure 2: The role of FBXL3 & FBXL21 in the circadian clock. FBXL3 acts as the
active E3 ligase, promoting CRY ubiquitin-mediated protein degradation. FBXL21 is
present in both the nucleus & cytoplasm & therefore plays two roles with respect to
its target substrate CRYs. FBXL21 in the nucleus antagonizes FBXL3, thereby
protecting CRYs from degradation; however in the cytoplasm, FBXL21 promotes
CRY ubiquitin-mediated protein degradation.
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1.4 Circadian influence on muscle physiology
The human body is composed of almost 50% skeletal muscle (Goodpaster et
al 2000; Hoppeler and Fluck 2002). Aside from enabling movement, skeletal muscle
plays important roles in maintaining overall health. Skeletal muscle serves as an
amino acid reservoir, a major site for postprandial glucose storage, and also an
endocrine tissue (Ripperger et al 1995; Defronzo et al 1981; Ferrannini et al 1988;
Febbraio and Pederson 2002). Recently, research groups have discovered circadian
gene expression via expression profiling in skeletal muscle tissue, suggesting that
up to 2,300 genes are circadian-regulated (McCarthy et al 2007; Pizarro et al 2013).
The role of the circadian system is still not completely known; however, it is plausible
that the circadian system plays multiple roles in the overall structure and function of
skeletal muscle, given the number of muscle-specific clock-controlled genes
(Harfmann et al 2015). Table 1 shows more examples of muscle-specific clockcontrolled genes that have physiological implications in several aspects of the proper
functioning of skeletal muscle. These genes are typically transcriptionally regulated
by core clock genes Clock and Bmal1.
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Table 1 Skeletal muscle-specific clock-controlled genes
Clock-controlled gene

Physiological
Implication

Reference

MyoD1

Glucose metabolism

Andrews et al 2010

Myogenin

Morphology,
myogenesis
Muscular dystrophy

Shavlakadze et al 2013

Fatty acid oxidation in
skeletal muscle cells

MacLellan et al 2005

Telethonin, Titin-cap
(TCAP)
Ucp3

Podobed et al 2014

1.5 Telethonin, a novel target substrate of both FBXL3 and FBXL21
Skeletal and cardiac muscle both require actin and myosin proteins for proper
contractile movements. However, it is only in the cardiac and skeletal muscle that
organized patterns of actin and myosin are bundled together into sarcomeres, which
form the basic contractile unit in striated muscle. The sliding motion of thick (myosin)
and thin (actin, tropomyosin, and troponin) filaments within sarcomeres allows
muscle contraction to occur, with each sarcomere being divided by z-discs (in
skeletal muscle, z-line in cardiac muscle). This is also where thin (actin,
tropomyosin, and troponin) filaments are anchored. These z-discs are highly proteinenriched areas of striated muscle, which is thought to be composed of z-disc protein
complexes (Faulkner et al 2001). Although some advances have been made, the
overall molecular organization of these z-disc proteins is still uncertain.
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Figure 3: Schematic of Telethonin (TCAP). TCAP is a sarcomeric Z-disc protein that is 19kDa
and sits at the end of TITIN protein. It is a critical regulator of both z-disc structure & function.
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Our lab recently identified Telethonin, also known as Titin cap or “Tcap”, as a
shared target substrate of FBXL3 and FBXL21. Tcap is a small (19kDa), cytoplasmic
protein that is expressed exclusively in the heart and skeletal muscle & is one of the
most abundant transcripts in striated muscle (Valle et al 1997). TCAP protein is
developmentally-regulated, as it has been shown to be expressed at lower levels in
neonatal animals than in adult animals. This gradual increase in expression was also
observed in C2C12 cells during myofibrillogenesis, which validated the in vivo data
(Mason et al 1999). Tcap (shown in Figure 3) co-localizes with actin in the thin
filaments of the Z-disc (Gregorio et al 1998). Within the sarcomere, Tcap binds to
two other z-disc proteins—FATZ and titin. In order to properly bind to titin, the first
140 amino acid residues of the protein must bind with the Z1 and Z2 Ig-like Nterminal repeat region of titin (Mues et al 1998). Interestingly, Tcap and its protein
product show clear circadian, diurnal expression patterns in mice and blunted cyclic
expression in circadian mutant mice (Podobed et al 2014).
Although small, Tcap is essential to proper structure and function of cardiac
and skeletal muscle. At least two different mutations in Tcap have been associated
with a form of autosomal recessive limb-girdle muscular dystrophy (AR LGMD) type
2G. This form of the disease has a milder phenotype than other genetically distinct
types of AR LGMD. Clinical features include significantly weakened distal leg
muscles, calf hypertrophy, and elevated serum creatine-kinase levels. Many of these
patients eventually lose the ability to walk near middle age. Moreira et al 200
showed that these particular mutations affect the carboxy-terminal region of the
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Tcap gene, which then has the potential to affect the sarcomeric structure of skeletal
muscle (Moreira et al 2000). LGMD2G has been modeled in a TCAP knockout
mouse that has a null mutation in the TCAP gene. Interestingly, this mouse exhibits
a much less severe phenotype compared to LGMD2G patients, with the biggest
impact in balance and muscle stiffness (Markert et al 2010). The disparity between
the human and mouse phenotypes is most likely due to the mutation type—null (KO
mouse) vs dominant negative (patients). Moreover, mutations in the Titin gene itself
have been associated with dilated cardiomyopathy (DCM), which causes systolic
dysfunction and ventricular dilation. (Itoh-Satoh et al 2002). TITIN is a large protein
that is also expressed in cardiac and skeletal muscle and has been shown to interact
with sarcomeric proteins, including TCAP (Bang et al 2001). Here, researchers
found that two of the mutations (Val54Met and Ala743Val) mapped to the Z-line
portion of Titin decreased TITIN protein’s ability to bind to its usual sarcomeric
targets, one of them being TCAP; therefore, a subset of Titin mutations affect
sarcomeric assembly via TCAP (Itoh-Satoh et al 2002). Considering Tcap’s vital role
in cardiac and skeletal muscle physiology, it is plausible that FBXL3 and FBXL21
regulate skeletal muscle physiology by tightly controlling TCAP protein levels.

1.6 Central hypothesis & specific aims
We hypothesize that FBXL3 and FBXL21 coordinately regulate skeletal muscle
physiology via ubiquitin-mediated protein degradation of their shared target
substrate TCAP.

16

Specific Aim 1: To characterize the circadian timing of TCAP expression in wild-type
and Past-time muscle tissues. We will collect skeletal (gastrocnemius) and cardiac
muscle tissue from adult wild type and FBXL21 mutant (Psttm) mice at CT 0, 4, 8,
12, 16, and 20 to investigate endogenous protein expression of TCAP over a full
circadian cycle. We hypothesize that TCAP expression in Psttm muscle tissue will
display an abnormal (overall increase) expression due to the point mutation in
Fbxl21.

Specific Aim 2: To assess the roles of FBXL3 and FBXL21 in TCAP degradation. We
will measure TCAP protein stability in the presence of either E3 ligases to determine
how FBXL3 and FBXL21 affect TCAP degradation. We hypothesize that FBXL21 will
decrease TCAP stability and FBXL3 will increase TCAP stability.

Specific Aim 3: To construct a viral expression vector for the overexpression of
FBXL3 and FBXL21 in a skeletal muscle in vitro model. We will remove FBXL3/21
insert from the pCMV10-3XFlag and subclone into the pFUW lentiviral vector to
overexpress FBXL3/21 in vitro. We hypothesize that FBXL3/21 will be sufficiently
expressed in vitro.

17

CHAPTER 2: MATERIALS & METHODS

18

2.1 Mouse strains
C57BL/6J (Stock # 000664) mice were purchased from Jackson Laboratory (Bar
Harbor, ME). Psttm/Psttm (“Past-time”) mutant mice were cloned by Dr. Seung-Hee
Yoo. The Past-time mouse line was generated from ENU mutagenesis as previously
described (Yoo et al 2013). All mice were group-housed according to genotype and
maintained under LD 12:12 conditions with food and water provided ad libitum. All
animal care and procedures were approved by the Animal Care and Use Committee
of the University of Texas Health Science Center in Houston.
2.2 DNA extractions & Past-time genotyping
Genotyping was performed using DNA derived from a 2 mm tail tip extracted
from each Past-time mouse. To extract genomic DNA, tail tips were placed in a 1.5
mL micro-centrifuge tube and heated to 95⁰C with 90 uL 50 mM NaOH for 45
minutes. To neutralize the extract, 10 uL 1M Tris (pH 4.7) was added to each
sample and the DNA extract was vortexed. To genotype by PCR analysis, the DNA
extract was diluted 1:5 with nuclease-free water and stored at 4⁰C.
Past-time mice were maintained as homozygote breeding pairs (2 PSTM
homozygote females, 1 PSTM homozygote male), so the resulting progeny did not
require genotyping. Past-time genomic DNA was amplified during PCR using
forward (5’CAGAACTCGGTTGCTGGATT-3’) and reverse
(5’CAGCAACTCCGTCTTTCCTC-3’) primers at 100uM. PCR products are purified
using the QIAquick Gel Extract kit (Qiagen) and then submitted to GeneWiz for
sequencing to detect single nucleotide polymorphisms. The PSTM wild-type and
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PSTM homozygous sequences are as follows: CCTTGGGATTG and
CCTTGGAATTG.
2.3 Tissue collection
C57BL/6J and Psttm mice were maintained in LD 12:12 and then moved to constant
darkness (DD) 36 hours prior to tissue collection at 13 weeks of age. Mice were
sacrificed by cervical dislocation under infrared lights at CT 0, 4, 8, 12, 16, and 20.
Gastrocnemius and tibialis anterior tissue was harvested under normal white light.
Tissue was sectioned into 50-100mg pieces, immediately snap-frozen in dry ice and
then placed in a pre-chilled 1.5mL micro-centrifuge tube to prevent proteasomal
degradation. Prior to protein extraction, tissue samples were stored at -80⁰ Celsius.
A one-inch portion of the tail was also collected and frozen to verify the genotype of
any given mouse, if necessary, for future experiments.
2.4 Protein extractions
Frozen mouse tissue was immersed in a total of 500uL of cold extraction
buffer & then homogenized with an electric homogenizer. To fully disrupt the lysate,
samples were vortexed at 3000rpm for 30 seconds every 5 minutes for a total of 15
minutes. Samples were then centrifuged at 13,000 rpm for 20 minutes at 4⁰ C and
the supernatant was aspirated (avoiding any lipid or other insoluble materials) into a
fresh tube and kept on ice for protein quantification. To quantify protein
concentrations, we performed the Bradford Assay as previously described Bradford,
MM 1976 and measured the optical density (OD) of each sample at 595 nm on the
Tecan plate reader. Lysate was diluted with EB first until all samples were 2ug/uL
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and then with one-fifth volume 5x Laemmli loading buffer and lastly boiled at 95⁰ C
for 5 minutes to denature the quarternary structure of the protein samples.
2.5 Immunoblotting
10-12ug of WT and Psttm muscle lysate was resolved by SDS-PAGE and Western
Blotting analysis. The following antibodies were used: TCAP 1:1000 (BD
Biosciences, Abcam), FBXL21 1:2000 (generated as specified in Yoo et al 2013),
FBXL3 1:3000 (generated as specified in Yoo et al 2013), GAPDH 1:10000
(Ambion), FLAG 1:1000 (Sigma). Relative protein abundance was quantified using
ImageJ (Schneider et al 2012) and two-way ANOVAs were performed to measure
differences between WT and Psttm expression across circadian time on GraphPad
Prism software. Error bars represent ± SEM (n=3).
2.6 Cell Culture & Transfection
The C2C12 cell line (ATCC) is commonly used to model skeletal muscle
differentiation. C2C12 myoblasts were thawed from a frozen stock and maintained as
myoblasts in high glucose + glutamine Dulbecco’s Modified Eagle Medium (DMEM)
with 10% Fetal Bovine Serum (FBS) and 1% Penicillin/Streptomycin. To prevent
differentiation into myotubes, C2C12 cells were subcultured at 80-90% confluency.
To perform the TCAP protein degradation assay, C2C12 cells were plated into
two 6-well plates at 1 ˣ 105 per well 17 hours before transfection. Cells were then
transfected with Tcap with or without Fbxl3 or Fbxl21 constructs using Effectene
transfection reagent (Qiagen). 40ug/mL cycloheximide (CHX) was then added to
each well 24 hours after transfection. To confirm functionality of the FBXL3/2121

expressing lentivirus constructs, HEK 293T cells were plated at 1 ˣ 105 per well in a
6-well plate, then transfected 17 hours later using Effectene transfection reagent
(Qiagen). 24 hours after transfection, FBXL3/21 expression was confirmed via
confocal microscopy and immunoblotting. To produce the FBXL3/21 lentiviruses,
293T cells were plated in a polyD lysine-coated 10cm dish at 6.0 ˣ 106 in antibioticfree 10% FBS media. The 293T cells were transfected with pCMV-deltaR8.91 and
pVSV-G packaging vectors with Lipofectamine 2000 transfection reagent (Thermo
Fischer Scientific). 12-16 hours after transfection, the Lipofectamine-containing
media was replaced with complete media for 293T cells. 48 hours later, the viruscontaining supernatant was transferred to a polypropylene tube and centrifuged at
4,000 rpm for 10 minutes to remove the remaining 293T cells. The virus was then
filtered using a 0.45 um cellulose acetate filter and stored at 4⁰ C for short-term
storage and -80⁰ C for long-term storage.
2.7 Plasmids
Fbxl3 and Fbxl21 cDNA was synthesized as specified in Yoo et al (2013).
2.8 TCAP degradation assay
C2C12 cells were treated with 40ug/mL of cycloheximide for 0, 2, 4, or 6 hours.
Cycloheximide is a commonly used reagent to inhibit protein synthesis by preventing
the elongation step of eukaryotic translation [Schneider-Poetsch et al 2010]. At the
end of each indicated treatment time, C2C12 cells were lysed and used for
immunoblotting. Half-life parameter K was calculated using one-phase decay.
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Statistical difference between half-life parameter K was calculated by one-way
ANOVA. Error bars represent ± SEM (n=3).
2.9 Lentiviral construction
To improve transfection efficiency of C2C12 cells, a lentivirus system with GFP
markers has been employed for the muscle differentiation experiment. Full-length
Fbxl3 and Fbxl21 cDNA (tagged with a Flag sequence) was digested from its original
vector, pCMV10-3XFlag (Sigma) and subcloned into the pFUW lentivirus vector. To
confirm the insert sequence, lentivirus vectors expressing Fbxl3 and Fbxl21 were
submitted to GeneWiz. To confirm functionality of these lentivirus vectors in vitro,
293T cells were transfected with both vectors using Effectene reagent (Qiagen),
lysed 24 hours later, and Fbxl3 and Fbxl21 expression was confirmed via
immunoblotting.
2.10 Statistical Analysis
All statistical analysis was performed in GraphPad Prism (Version 5). Twoway ANOVA analysis was performed to compute the differences in protein
expression between WT and Psttm muscle tissues across six circadian time points.
Two-way ANOVA analysis helps to determine how the dependent variable is
affected by two variables or factors. In this case, both the genotype of each mouse
that the muscle tissue was collected from and circadian time contribute to the
response (protein expression). Error bars represent ± SEM (n=3).
Half-life of TCAP protein alone or in the presence of FBXL3/21 was
determined using one-phase decay analysis, where K is the half-life parameter. This
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statistical test was chosen because cycloheximide treatment results in only one
decay phase as opposed to multiple phase decays. One-way ANOVA analysis was
performed to compute the statistical difference between half-life parameter, K, for
each condition. Error bars represent ± SEM (n=3).
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CHAPTER 3: RESULTS
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3.1 Circadian timing of TCAP protein expression in skeletal muscle
Preliminary experiments validated our novel finding that TCAP is a shared
protein target of E3 ligases FBXL3 and FBXL21. This homologous pair was shown
to differentially affect TCAP expression in HEK293T cells. Yoo et al (2013) reported
that FBXL3 was the dominant E3 ligase in CRY protein degradation, while FBXL21
was considered to be a regulatory E3 ligase. Unexpectedly, FBXL21 was much
more potent in TCAP degradation than FBXL3, suggesting that FBXL21 is the
primary E3 ligase in ubiquitin-mediated protein TCAP degradation. These newly
identified FBXL3/21-TCAP interactions directly oppose the previous mechanism
established in (Yoo et al 2013) in which FBXL3 was the active E3 ligase and
FBXL21 was predominantly a regulatory ligase for the CRYPTOCHROME (CRY)
substrates. This difference in E3 ligase-substrate activity highlights the importance of
substrate specificity in characterizing E3 ligases’ cellular function(s). TCAP is ranked
as the 12th most abundant transcript in skeletal muscle tissue (Valle et al 1997) and
is a circadian-regulated transcriptional target (Podobed et al 2014). We therefore
isolated WT and Psttm gastrocnemius (skeletal) muscle to characterize the circadian
timing of TCAP protein expression. We hypothesize that the instability of Fbxl21 in
the Psttm mutant mice will lead to elevated TCAP protein levels throughout the
circadian cycle under normal (12:12 LD conditions).
We observed a circadian oscillation of TCAP protein with a peak at CT16 in
WT mice (Figure 4), whereas the Psttm mutation caused a significant increase in
overall TCAP protein expression. This increase in expression is consistent with our
sub-hypothesis that TCAP protein expression would be elevated throughout the
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circadian cycle due to the lack of stability in Fbxl21 in Psttm mice. We also observed
a circadian oscillation in FBXL21 protein, with a slight phase advance in expression
compared to TCAP protein expression. FBXL21 protein expression is unstable
throughout the circadian cycle in Psttm skeletal muscle, as expected (Yoo et al
2013). FBXL3 was constitutively expressed in both WT and Psttm tissue, consistent
with the literature that shows that FBXL3 is not circadian regulated (Yoo et al 2013).
Most importantly, two-way ANOVA analysis shows significant (p<0.001) genotype
effect on TCAP and FBXL21 protein expression, and TCAP protein expression is
elevated throughout the entire circadian cycle in PSTM homozygous mice compared
to PSTM WT mice. Interestingly, when TCAP protein expression is highest (CT16),
FBXL21 protein expression was low as shown in Figure 5A. This observation is
consistent with our preliminary results, which implies that TCAP expression should
be highest when the active E3 ligase (FBXL21) is not present or expressed at
relatively low levels.
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Figure 4: Circadian timing of TCAP protein expression in skeletal muscle. Mice
were sacrificed at CT 0, 4, 8, 12, 16, and 20 under infrared lights and Western Blots
were performed with whole protein lysate (extracted from gastrocnemius muscle)
using the indicated antibodies. Representative Western Blots are shown to the left
with corresponding quantifications on the right. In the plots, blue data points denote
WT mice and red data points represent PSTM homozygote protein expression. Twoway ANOVA analysis shows significant (p<0.001) differences between WT and
Psttm protein levels of TCAP and FBXL21. Error bars represent mean ± SEM (n=3).
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3.2 Circadian timing of TCAP protein expression in cardiac muscle
TCAP is also a critical regulator of sarcomeric z-disc structure and function in
cardiac muscle (heart) (Valle et al 1997). To further characterize TCAP protein
expression throughout the circadian cycle, we isolated WT and Psttm heart tissue.
Again, we observed a circadian oscillation of TCAP protein in WT heart tissue with a
peak at CT16 (Figure 6) and significantly elevated levels of TCAP protein throughout
the circadian cycle. FBXL21 protein expression displayed a moderate oscillatory
pattern across the circadian cycle in WT mice, but was unstable in Psttm mice, due
to the point mutation in Fbxl21. FBXL3 protein showed slight fluctuations in
expression throughout the circadian cycle in WT cardiac muscle, but this is not due
to circadian regulation. FBXL3 protein expression in Psttm cardiac muscle was
found to be unstable. Overall, two-way ANOVA analysis showed significant
(p<0.001) genotype effect on TCAP protein expression, and again TCAP protein
expression is elevated throughout the entire circadian cycle in cardiac muscle of
PSTM homozygous mice compared to PSTM WT mice.
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Figure 5: Circadian timing of TCAP protein expression in cardiac muscle. Mice were
sacrificed at CT 0, 4, 8, 12, 16, and 20 under infrared lights and Western Blots were
performed with whole protein lysate (extracted from heart tissue) using the indicated
antibodies. Representative Western Blots are shown to the left with corresponding
quantifications on the right. In the plots, blue data points denote WT mice and red data points
represent PSTM homozygote protein expression. Two-way ANOVA analysis shows significant
(p<0.001) differences between WT and Psttm protein levels of TCAP. Error bars represent
mean ± SEM (n=3).
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3.3 TCAP degradation by FBXL3 or FBXL21
Based on our Yeast Two Hybrid screening results, we performed a protein
half-life experiment to determine the stability of TCAP protein with or without FBXL3
or FBXL21 in HEK293T cells. Unlike the previous study of these two homologous E3
ligases, TCAP was least stable in the presence of FBXL21, suggesting that FBXL21
is the active E3 ligase in TCAP ubiquitin-mediated protein degradation. Although
unexpected, this change in E3 ligase activity is reasonable, considering that FBXL21
and TCAP are both either predominantly or completely cytoplasmic proteins, in
addition to both being subject to circadian regulation (Yoo et al 2013; Valle et al
1997). Because this experiment was performed in a cell line that lacks physiological
relevance to cardiac or skeletal muscle, the half-life experiment was then performed
in C2C12 myoblasts. The C2C12 cell line is derived from primary mouse myoblasts
and can be differentiated into myotubes, thus making this cell line effective for
modeling mammalian myogenesis (Burattini et al 2004).
To measure the half-life of TCAP protein, C2C12 cells were co-transfected
with TCAP and either FBXL3 or FBXL21. 24 hours after transfection, cells were
treated with cycloheximide (CHX), a protein synthesis inhibitor, which effectively
facilitates measurement of protein degradation of pre-existing proteins. Interestingly,
our TCAP degradation assay results differed from our preliminary results (in
HEK293T cells), which emphasizes the importance of context in characterizing E3
ligase activity paradigms. In 293T cells, FBXL21 was found to be the active E3
ligase, whereas FBXL3 increased TCAP stability increased TCAP protein
expression. TCAP protein stability was still negatively affected by FBXL21 coexpression in C2C12 cells; however, FBXL3 was unexpectedly found to also be a
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weaker, but still active E3 ligase in TCAP ubiquitin-mediated protein degradation
(Figure 7). TCAP, when co-expressed with either FBXL3 or FBXL21, exhibited a
decrease in protein stability and therefore a shorter half-life. This differential
degradation pattern was noted as early as the 2-hour CHX treatment time point.
TCAP was nearly diminished after 6 hours of CHX treatment, so half-life
quantification is based on 4 hours of CHX treatment. Here, we observed that both
FBXL3 and FBXL21 were active E3 ligases, although FBXL21 was the stronger,
more efficient ligase.
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Figure 6: Two homologous E3 ligases expression increases TCAP degradation in
C2C12 myoblasts. C2C12 myoblasts were co-transfected with the constructs indicated
above. 24 hours later, these cells were treated with 40ug/mL cycloheximide and
harvested at either 0, 2, 4, or 6 hours post-treatment. Western Blotting was performed to
detect TCAP protein levels under three conditions in addition to GAPDH for loading
control. Left: representative Western Blots of TCAP protein expression, bottom:
quantification of representative Western Blots. Half-life of TCAP protein was determined
by non-linear, one-phase exponential decay analysis. TCAP half-life alone: 2.277 hr,
TCAP + FBXL3: 1.914 hr, TCAP + FBXL21: 1.392. One-way ANOVA shows no significant
difference in half-lives, but there is a noticeable difference at time points 2 and 4 hr.
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3.4 Lentiviral constructs expressing FBXL3 and FBXL21 are functional in vitro
To achieve sufficient overexpression in C2C12 cells, we chose a lentiviral
system. These lentiviral constructs will be used for future experiments investigating
the cellular function and biochemical mechanism of FBXL3/21 in in vitro models of
skeletal muscle. I have created two lentiviral constructs expressing FBXL3 and
FBXL21 by first removing the FBXL3/21 inserts from their original vector, pCMV103XFlag (Sigma) and subcloning them into a pFUW lentiviral vector that allows for
lentiviral transduction when introduced into HEK293T cells with two packaging
vectors, pCMV-deltaR8.91 and pVSV-G. This final aim of creating the lentiviral
constructs expressing FBXL3/21 was necessary for further in vitro studies.
After subcloning was complete, small aliquots of each plasmid were
submitted to GeneWiz for sequencing. Once sequencing was confirmed, plasmids
were transduced in HEK293T cells and cells were harvested 24 hours posttransduction. As shown in Figure 8, both FBXL3/21 were successfully subcloned and
expressed in vitro. Adequate protein levels were detectable via both Western blotting
analysis and confocal microscopy.
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B
Fbxl3-LV Control

Fbxl21-LV
Concentration (ng)

Concentration (ng) 100 300 600 900 100 300

WB: Flag

WB: Flag

Fbxl3-LV

Fbxl21-LV

300 300

Figure 5: FBXL-expressing lentiviral constructs are functional in vitro. (A) top: representative
Western Blot of FBXL3, bottom: representative GFP image expressing Fbxl3 cDNA. (B) top:
representative Western Blot of FBXL21, bottom: representative GFP image expressing Fbxl21
cDNA. Lentiviral constructs expressing FBXL3/21 were transduced in HEK293T cells 17 hours later.
24 hours post-transduction, GFP images were taken and cells were harvested for Western Blotting
analysis.
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CHAPTER 4: DISCUSSION & FUTURE DIRECTIONS
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4. Discussion
There are an estimated 600 E3 ubiquitin ligases in the human genome and
the majority of them are understudied (Grabbe et al 2011; Harper et al 2012).
Subsets of E3s share high sequence homology, thus allowing them to share one or
more protein targets for proteasomal degradation. Yoo et al (2013) found that CRY
proteins are substrates of both FBXL3 and FBXL21, two homologous F-boxcontaining E3 ligases. Localization studies showed that FBXL3 predominantly
resides in the nucleus, whereas FBXL21 resides in both the nucleus and the
cytoplasm. When present with its substrate, FBXL3 acts as an active E3 ligase,
targeting CRY for degradation; however; FBXL21 antagonizes this activity when
present in the nucleus and actually protects CRY from degradation. On the other
hand, FBXL21 is capable of targeting CRY for proteasomal degradation in the
cytoplasm, although less efficiently than FBXL3. This discovery lead to the
elucidation of a previously unknown paradigm for homologous mammalian E3
ligases. To further understand the cellular function(s) of this pair, we conducted a
Yeast 2-Hybrid screen in skeletal muscle to find additional shared substrates and we
identified TCAP as a novel shared target substrate of FBXL3 and FBXL21. We then
aimed to elucidate the role of FBXL3 and FBXL21 in regulating muscle physiology
via TCAP ubiquitin-mediated protein degradation. Here, we show that the circadianregulated FBXL21 is the more efficient E3 ligase in TCAP protein degradation, with
implications for myogenesis in skeletal muscle.
TCAP protein showed an oscillatory expression pattern, suggesting that it is
circadian regulated in both murine skeletal and cardiac muscle. TCAP has been
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previously reported as a transcriptional target of circadian machinery, with both
protein and gene expression peaking near the early dark phase in murine cardiac
muscle (Podobed et al 2014), so our data is consistent with the literature. In both
instances, peak expression was observed in the dark phase of the circadian cycle
(CT 16), which is also the active phase for mice. Circadian rhythms influence genes
that are responsible for transcription, metabolism, and myogenic capacity in skeletal
muscle, allowing all of these processes to anticipate environmental changes, which
is highly beneficial from an evolutionary perspective (Andrews et al 2010; Chatterjee
et al 2011; Zhang et al 2012). In the heart, TCAP is vital to both mechanical and
signaling processes (Zou et al 2006) and can lead to contractile and mechanical
sensing defects when genetically ablated (Ibrahim et al 2013). Additionally,
contractile performance in the heart has been reported to vary over time (Young et al
2001), providing even more evidence that the circadian system heavily influences
the muscular system. Taken together, it can be deduced that the circadian system
functions to maintain normal cardiac functioning. Based on our differentiation
experiments, we assume the same is true for circadian regulation of TCAP protein in
skeletal muscle. In gastrocnemius muscle, TCAP protein expression peaks at the
time that FBXL21 protein expression is lowest, while FBXL3 protein expression
remains relatively constant. This finding suggests that TCAP undergoes double
circadian regulation—transcriptionally and post-translationally (protein degradation).
The phenotype of the Psttm mouse might be interesting to investigate given
the proposed relationship of TCAP and FBXL21 in muscle tissue. As previously
stated, the Psttm mouse has a semidominant, hypomorphic mutation in the Fbxl21
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gene. This mutation is expected to affect the LRR domain of FBXL21 protein, which
is likely to affect substrate recognition and thus, protein-protein interactions (Yoo et
al 2013). One striking feature of the Psttm mutant mouse is the size difference that is
evident from birth. The weaning date is typically extended up to 7 days for these
mice because they are smaller than normal pups. Again, skeletal muscle accounts
for about 45% of the body (Goodpaster et al 2000; Hoppeler and Fluck 2002), so if
there is a deficiency in skeletal muscle development (and possibly function) due to
ineffective E3 ligase regulation of TCAP by FBXL21, this could potentially contribute
to the low bodyweight observed in Psttm mice. Preliminary weight measurements of
Psttm WT and homozygote littermates (data not shown) are consistent with this
observation; further detailed investigation of the skeletal muscle phenotype in Psttm
mice will be conducted in the future.
Another important finding is that both FBXL3 and FBXL21 appear to act as
active E3 ligases in C2C12 myoblasts, although FBXL21 is the more potent of the
two (pictured in Figure 8). This was unexpected on two fronts: 1) FBXL3 was the
only known active E3 ligase in CRY-targeted proteasomal degradation and 2) our
preliminary experiments in 293T cells lead us to believe that only FBXL21 would be
the active E3 ligase for TCAP proteasomal degradation. Given the current literature
about TCAP’s role in cardiac and skeletal muscle, this paradigm is most likely to
affect myogenesis & subsequent muscle functioning. Upon further scrutiny of these
results, it is quite possible that FBXL3 and FBXL21 are both degrading TCAP protein
in these cells because we analyzed the whole cell lysate. TCAP is known to be a
cytoplasmic protein (Valle et al 1997); however, we have yet to directly check where
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this protein localizes when overexpressed. Limb girdle muscular dystrophy type 2G
(LGMD2G) patients have been found to lack TCAP protein in the sarcomeric regions
in type 1 and 2 fibers obtained from muscle biopsies, but instead some antitelethonin fluorescence labeling was present in nuclei. It is, however, important to
note that these patients all have autosomal recessive mutations in Telethonin
(TCAP) (Vainzof et al 2002). If overexpressed TCAP does translocate to the nucleus
at some point, FBXL3 might be a less efficient E3 ligase that only functions in the
nucleus, causing us to observe both E3 ligases activities at once. Nevertheless, this
finding is interesting and emphasizes the importance of substrate specificity for
characterizing E3 ligases and their substrate-ligase paradigm.
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Figure 8: The role of FBXL3 & FBXL21 in muscle physiology. Our data suggests
that FBXL3 and FBXL21 both accelerate TCAP protein degradation. Moreover, TCAP
is more rapidly degraded in the presence of FBXL21, a protein that is circadian
regulated and primarily cytoplasmic. FBXL3 is also capable of promoting proteasomal
degradation of TCAP, but to a lesser extent than FBXL21.
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Broadly speaking, there are multiple lines of evidence suggesting that skeletal
muscle is circadian regulated; however, there is still no definitive answer to the
question, “Why is muscle circadian regulated?” Some studies have, however,
provided some insight into this phenomenon. CLOCK, an important component of
the circadian molecular oscillator, has been shown to play an important role in
mitochondrial maintenance in skeletal muscle. Moreover, mice with a genetic
disruption in the Clock gene exhibited a diminished ability to recover from chronic
exercise. Interestingly, this inability to adapt to chronic exercise was reduced after
endurance training (Pastore and Hood 1985). Since then, exercise has been shown
to be a non-photic entrainment cue of the circadian system as evidenced in
Schroeder et al (2012). Scheduled exercise had various effects on wildtype and VIPdeficient mice, but notably it enhanced the phase and amplitude of
PER2::LUCIFERASE expression rhythms in both the core and peripheral clocks of
the Per2::Luc mice. Considering these findings and the many functions of skeletal
muscle throughout the body, it is possible that circadian regulation of skeletal muscle
has implications for metabolic functioning, circadian rhythm synchrony, locomotor
activity, and mitochondrial functioning. The specific role of TCAP in relation to
circadian regulation still remains elusive, but it most likely has the largest influence in
mechanical stability or mechano-sensing.
4.1 Future Directions
Based on these findings, there are several directions to explore. Although we
revealed the role that FBXL3 and FBXL21 play in TCAP protein degradation, the
spatiotemporal mechanism has yet to be fully elucidated. Where do the SCFTCAP,
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SCFFBXL3, and SCFFBXL21 complexes localize and at what times do these complexes
form? Because both FBXL3 and FBXL21 were found to facilitate degradation of
TCAP to similar degrees, we assume that both E3 ligases form SCF complexes;
however, this has not been confirmed. We expect that FBXL3 is predominantly
present in the nucleus and forms an SCF complex with Skp1 and Cul1, but is a
weaker E3 ligase because TCAP is a cytoplasmic protein (Valle et al 1997). We also
expect FBXL21 to form an SCF complex in the cytoplasm because it has been found
to do so in the past (Yoo et al 2013). In light of the in vitro results, a closer
examination of the Past-time mouse model is also warranted to better understand
the physiological impact of TCAP post-translational regulation via FBXL3 and
FBXL21 E3 ligase activity. How does the skeletal muscle develop in young and adult
Past-time (Fbxl21 mutant) and Overtime (Fbxl3 mutant) mice compared to WT
mice? Other potential avenues of investigation include ubiquitin chain linkage type
and other shared substrates based on the Yeast 2-Hybrid screen.
Our next experimental aim is to determine whether FBXL3 and/or FBXL21
affects muscle differentiation in vitro. We will infect C2C12 myoblast cells with a
lentivirus expressing either FBXL3 or FBXL21 and visualize the subsequent effects
on myotube differentiation. I have created two lentiviral constructs expressing FBXL3
and FBXL21, so the next step is to transfect these plasmids with two packaging
vectors (pCMV-deltaR8.91 and pVSV-G) into 293T cells, harvest the virus and
concentrate it with the Lenti-X Concentrator (ClonTech). To objectively measure the
effect of overexpressing these E3 ligases, we will harvest muscle cells and measure
the expression levels of differentiation markers and endogenous TCAP over the
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course of the differentiation process. We hypothesize that FBXL21 overexpression
will promote rapid TCAP degradation & therefore hinder muscle differentiation.
TCAP is a newly identified shared target substrate of FBXL3 and FBXL21. It’s
importance to the anatomy and physiology of skeletal muscle implies that E3 ligase
regulation of TCAP degradation serves an important physiological purpose.
Interestingly, TCAP protein expression is highest when FBXL21 protein expression
is low, which we reason that TCAP accumulation can occur in the absence of its E3
ligase, FBXL21. When co-transfected with TCAP, FBXL3 and FBXL21 both
decrease TCAP protein half-life, suggesting that they affect TCAP protein stability
via ubiquitin-mediated protein degradation. These results were initially surprising
because FBXL3 was the primary, active E3 ligase in CRY ubiquitin-mediated protein
degradation. More importantly, the reversal of roles highlights the importance of
substrate specificity in characterizing homologous E3 ligase paradigms. These two
paradigms may serve as a guide for future mechanistic studies of other understudied
E3 ligases.
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